Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v3-EN
Language English English
Date Updated 2019-09-14 2019-09-14
Drug Identification Number 02247815 02247815
Brand name RIVA-RANITIDINE 300 RIVA-RANITIDINE 300
Common or Proper name Riva-Ranitidine 300 Riva-Ranitidine 300
Company Name LABORATOIRE RIVA INC. LABORATOIRE RIVA INC.
Ingredients RANITIDINE RANITIDINE
Strength(s) 300MG 300MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 & 100 30 & 100
ATC code A02BA A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2019-09-13 2019-09-13
Actual start date 2019-09-13 2019-09-13
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Health Canada imposed distribution restriction Health Canada imposed distribution restriction
Health Canada comments